HLA class, calcineurin inhibitor levels, and the risk of graft failure in kidney recipients with de novo donor-specific antibodies
The prognosis of patients with dnDSA is similar regardless of the HLA class specificity. Lower calcineurin inhibitor levels predict graft loss in such patients.
Authors
- Éva Latulippe
- Julie Lesage (ORCID: https://orcid.org/0000-0002-9186-5290)
- Isabelle Lapointe
- Sacha A. De Serres (ORCID: https://orcid.org/0000-0002-7862-4935)
- Julie Riopel (ORCID: https://orcid.org/0000-0002-6583-0094)
- Olivier Désy
- Marc-Antoine Béland
- Isabelle Houde
- Isabelle Côté (ORCID: https://orcid.org/0000-0002-8360-9086)
- Éric Wagner
Institutions
- Université Laval (CA)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-20
- DOI
- https://doi.org/10.3389/fimmu.2024.1493878
- Citations
- 2
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.02
Funders
- Canadian Institutes of Health Research
- Fonds de Recherche du Québec - Santé